Cost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry.

Cost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry.

Item
http://www.wikidata.org/entity/Q34077022

Cost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry.

Item
http://www.wikidata.org/entity/Q34077022
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cost-effectiveness analysis of ...... dish prescribed drug registry.
@ast
Cost-effectiveness analysis of ...... dish prescribed drug registry.
@en
Cost-effectiveness analysis of ...... dish prescribed drug registry.
@nl
type
label
Cost-effectiveness analysis of ...... dish prescribed drug registry.
@ast
Cost-effectiveness analysis of ...... dish prescribed drug registry.
@en
Cost-effectiveness analysis of ...... dish prescribed drug registry.
@nl
prefLabel
Cost-effectiveness analysis of ...... dish prescribed drug registry.
@ast
Cost-effectiveness analysis of ...... dish prescribed drug registry.
@en
Cost-effectiveness analysis of ...... dish prescribed drug registry.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Cost-effectiveness analysis of ...... edish prescribed drug registry
@en
P2093
P2860
P304
P31
P356
10.1111/J.1464-410X.2011.10729.X
P433
P478
P50
P577
P698